Synonyms FKSG80, G protein-coupled receptor 104, G protein-coupled receptor 81 + [10] |
Introduction Acts as a receptor for L-lactate and mediates its anti-lipolytic effect through a G(i)-protein-mediated pathway. |
Target |
Mechanism HCAR1 antagonists [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date12 Aug 1955 |
Target |
Mechanism HCAR1 antagonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism HCAR1 agonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Jun 2022 |
Sponsor / Collaborator |
Start Date01 Jul 2016 |
Sponsor / Collaborator |
Start Date23 Jul 2015 |
Sponsor / Collaborator |